Wall St Week Ahead: Nvidia earnings in focus as rising US yields, debt rattle markets
NEW YORK: An earnings report from semiconductor giant and artificial intelligence bellwether Nvidia takes center stage for Wall Street in the coming week, as stocks hit a speed bump of worries over federal deficits driving up Treasury yields.
U.S. equities pulled back this week after a torrid rally, as investors turned their attention to tax and spending legislation poised to swell the U.S. government's $36 trillion in debt. Long-dated U.S. Treasury yields rose amid the fiscal worries, with the 30-year yield topping 5% and hitting its highest level since late 2023.
Stocks were dealt another blow on Friday when U.S. President Donald Trump targeted the European Union and Apple in threats to ratchet up his trade war.
Focus will shift to Wednesday's quarterly results from Nvidia, one of the world's largest companies by market value whose stock is a major influence on benchmark equity indexes.
"All eyes are going to be on Nvidia's report," said Chuck Carlson, CEO of Horizon Investment Services. "The whole AI theme has been a major driver of the market and Nvidia is at the epicenter of that theme."
Nvidia will be the last of the "Magnificent Seven" megacap tech and growth companies to report results for this period. Their stocks have been mixed in 2025 after leading the market higher as a group in the last two years.
Nvidia shares are down 2% this year after soaring over 1,000% from late 2022 through the end of 2024 as its AI chip business spurred massive increases in revenue and profits.
Nvidia's first-quarter earnings likely jumped about 45% on revenue of $43.2 billion, analysts estimated in an LSEG poll.
After big tech companies earlier in the quarter signaled robust AI-related spending, Nvidia can deliver a strong message about AI and how companies' spending plans are faring, said Art Hogan, chief market strategist at B Riley Wealth.
"Nvidia can reinvigorate the enthusiasm for that theme."
Nvidia, popular among smaller retail shareholders, is an investor sentiment indicator, said Wasif Latif, chief investment officer at Sarmaya Partners.
"Given its sheer size and attention that it is commanding, there are going to be a lot of people looking for what happens with the stock," Latif said.
U.S.-China relations could also be in focus with Nvidia's report. The company said last month it would take $5.5 billion in charges after the U.S. government limited exports of its H20 artificial intelligence chip to China.
Trade developments have whipsawed the stock market this year, especially after Trump's April 2 announcement of sweeping tariffs on imports globally set off extreme asset price volatility.
Since then, Trump's easing of tariffs, especially a U.S.-China truce, has helped equities rebound. The benchmark S&P 500 index ended on Friday down 1.3% for 2025, and down 5.6% from its February record high.
Stocks slipped on Friday after
Trump
pushed for a 50% tariff on European Union goods starting June 1 and threatened to impose a 25% tariff on Apple for any iPhones sold, but not made, in the United States.
Trump's fiscal plans consumed investor attention for much of the week, especially after Moody's downgraded the U.S. sovereign credit rating due to concerns about the nation's growing debt pile.
The U.S. House of Representatives, controlled by Trump's Republican party, on Thursday narrowly passed a tax and spending bill that would enact much of his agenda while adding an estimated $3.8 trillion to the debt over the next decade. The bill is heading to the U.S. Senate for its review.
Long-dated government bond yields have been rising globally amid a selloff, although they pulled back toward the end of the week. In the U.S., benchmark 10-year Treasury yields this week hit their highest since February. Bond prices move opposite to yields.
Higher yields can diminish the appeal of stocks as they represent higher borrowing costs for companies and consumers, while making fixed income assets relatively more attractive.
"The biggest concern from an investment standpoint is that higher rates represent more competition for equities," said Horizon's Carlson. "If rates continue to move higher, that is going to put increasing amounts of pressure on where investors are putting their money." (Reporting by Lewis Krauskopf; Editing by Richard Chang)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


TECHx
25 minutes ago
- TECHx
Why Generative AI Isn't a Silver Bullet for Healthcare
Home » Smart Sectors » Healthcare » Why Generative AI Isn't a Silver Bullet for Healthcare Generative AI is revolutionizing healthcare, but challenges remain. Ashley Woodbridge, Lenovo CTO META, explores why it's no silver bullet. The healthcare sector is on the brink of a significant surge in AI investment, projected to rise by an astounding 169% over the next year – the highest increase among all industries surveyed in EMEA. The uptick follows the promising early results of AI projects, where a remarkable 74% of healthcare AI pilot projects have met or exceeded expectations, with 13% surpassing them. Yet, despite this positive momentum, only 2% of healthcare organisations have actively deployed AI at scale with the majority of initiatives remaining in the pilot or planning stages. This raises the question: how can the industry and its partners move beyond this plateau? What is Generative AI Doing? For most people, their experience of Generative AI (GenAI), has been through conversations with chatbots, creating new content or summarising data. These lighter use cases have highlighted numerous challenges that must be addressed before widespread adoption can occur, especially in highly regulated industries like healthcare. One of the primary obstacles identified in the region wide survey is data quality. AI models, including GenAI, are only as effective as the data they are trained on. In healthcare, data often exists in silos, across incompatible systems, and in formats that are difficult to interpret. There are also important patient data privacy considerations to take into account. Despite the complexity involved in sorting and standardising this data, the potential benefits of tackling these issues and making it useable by AI are immense. For example, tools like Epic's 'Slicerdicer' allow healthcare professionals to query large datasets through conversational interfaces, uncovering important trends in patient outcomes and informing better care. The depth of queries is particularly powerful, allowing healthcare providers to uncover trends amongst patients that share a condition or illness that may have otherwise remained hidden. Taking the technology in a different direction, AI-powered 'ambient digital scribes' are being trialled by NHS doctors in the UK. These systems listen to patient appointments and automatically generate clinical notes, saving hours of administrative work and helping to reduce burnout among medical staff. However, healthcare providers must tread carefully. Public sentiment towards AI in healthcare remains cautious. Only 28% of people aged over 60 feel comfortable with AI technologies being used in their care, and 75% of consumers overall want to be informed if AI is being used in their healthcare communications. Transparency is critical. For AI to enhance patient experience without undermining it, trust must be maintained. In countries like the UAE and Saudi Arabia, AI algorithms are enhancing radiology by assisting in the analysis of medical images, enabling quicker and more accurate detection of conditions such as lung cancer. Predictive analytics are being utilized for real-time patient monitoring, allowing healthcare providers to intervene early in critical situations. Generative AI is also making strides in drug discovery, particularly in Qatar, where researchers are modelling molecular interactions to accelerate the development of new therapies. Additionally, AI-powered chatbots and virtual health assistants are streamlining telemedicine services, providing preliminary diagnoses and scheduling appointments, thus improving access to care. AI's Role in Medical Research Beyond frontline care, GenAI is turbocharging work in the field of medical research. Earlier this year, a researcher at Imperial College London used an AI tool developed by Google to investigate why certain bacteria are resistant to antibiotics. In just 48 hours, the tool proposed four viable hypotheses, whereas it had taken scientists over a decade to finalise just a single hypothesis manually. The result was so astonishing that the original researcher initially suspected the AI had accessed unpublished work on his personal computer, which was proven not to have been the case. These breakthroughs are being made possible thanks to the high-performance computing systems behind increasingly powerful AI models. At Lenovo, we are proud to partner with the Broad Institute on genome analysis, helping researchers accelerate one of the most data-intensive tasks in science. The Lenovo Genomics Optimization and Scalability Tool (GOAST) reduces the time needed to analyse a whole human genome from over 100 hours to just 47 minutes. Other organizations are also harnessing advanced AI and computing tools to push the boundaries of healthcare. Hungarian company 3DHISTECH, for example, uses Lenovo's AMD Threadripper-powered ThinkStation P620 workstations to build detailed 3D virtual models of human and non-human tissue. These models can zoom in to the level of individual chromosomes, enabling new frontiers in digital pathology. Their systems are used by institutions around the world, including Harvard Medical School, Novartis, and the Wuhan Institute of Virology. Notably, a 3DHISTECH system played a pivotal role in diagnosing the first COVID-19 patient in China, demonstrating how AI-enabled technology can impact global health crises. The Human Element Remains Crucial While AI offers compelling advantages, it's important to remember that technology alone isn't the answer. The human touch in healthcare remains indispensable. Healthcare providers must ensure transparency in their AI implementations and address data quality issues to fully reap the benefits of AI. By doing so, they can enhance patient care, reduce burnout among medical staff, and drive groundbreaking research, all without sacrificing the trust and comfort of those they serve. In conclusion, the healthcare industry stands at the brink of an AI-driven revolution. With thoughtful implementation and a focus on maintaining trust, AI has the potential to transform healthcare for the better. The journey won't be without its challenges, but the rewards promise to be well worth the effort. By Ashley Woodbridge, CTO, Lenovo, META


Dubai Eye
2 hours ago
- Dubai Eye
Rwanda, Congo sign peace deal in US to end fighting, attract investment
Rwanda and Democratic Republic of Congo signed a US-brokered peace agreement on Friday, raising hopes for an end to fighting that has killed thousands and displaced hundreds of thousands more this year. The agreement marks a breakthrough in talks held by US President Donald Trump's administration and aims to attract billions of dollars of Western investment to a region rich in tantalum, gold, cobalt, copper, lithium and other minerals. At a ceremony with US Secretary of State Marco Rubio in Washington, the two African countries' foreign ministers signed the agreement pledging to implement a 2024 deal that would see Rwandan troops withdraw from eastern Congo within 90 days, according to a copy seen by Reuters. Kinshasa and Kigali will also launch a regional economic integration framework within 90 days, the agreement said. "They were going at it for many years... it is one of the worst wars that anyone has ever seen. And I just happened to have somebody that was able to get it settled," Trump said on Friday, ahead of the signing of the deal in Washington. "We're getting, for the United States, a lot of the mineral rights from the Congo as part of it." Rwandan Foreign Minister Olivier Nduhungirehe called the agreement a turning point. Congo Foreign Minister Therese Kayikwamba Wagner said it must be followed by disengagement. Trump later met both officials in the Oval Office, where he presented them with letters inviting Congolese President Felix Tshisekedi and his Rwandan counterpart Paul Kagame to Washington to sign a package of agreements that Massad Boulos, Trump's senior adviser for Africa, dubbed the "Washington Accord". Nduhungirehe told Trump that past deals had not been implemented and urged Trump to stay engaged. Trump warned of "very severe penalties, financial and otherwise", if the agreement is violated. Rwanda has sent at least 7,000 soldiers over the border, according to analysts and diplomats, in support of the M23 rebels, who seized eastern Congo's two largest cities and lucrative mining areas in a lightning advance earlier this year. The gains by M23, the latest cycle in a decades-old conflict with roots in the 1994 Rwandan genocide, sparked fears that a wider war could draw in Congo's neighbours. ECONOMIC DEALS Boulos told Reuters in May that Washington wanted the peace agreement and accompanying minerals deals to be signed simultaneously this summer. Rubio said on Friday that heads of state would be "here in Washington in a few weeks to finalise the complete protocol and agreement". However, the agreement signed on Friday gives Congo and Rwanda three months to launch a framework "to expand foreign trade and investment derived from regional critical mineral supply chains". A source familiar with the matter told Reuters on Friday that another agreement on the framework would be signed by the heads of state at a separate White House event at an unspecified time. There is an understanding that progress in ongoing talks in Doha - a separate but parallel mediation effort with delegations from the Congolese government and M23 - is essential before the signing of the economic framework, the source said. The agreement signed on Friday voiced "full support" for the Qatar-hosted talks. It also says Congo and Rwanda will form a joint security coordination mechanism within 30 days and implement a plan agreed last year to monitor and verify the withdrawal of Rwandan soldiers within three months. Congolese military operations targeting the Democratic Forces for the Liberation of Rwanda (FDLR), a Congo-based armed group that includes remnants of Rwanda's former army and militias that carried out the 1994 genocide, are meant to conclude over the same timeframe.


The National
4 hours ago
- The National
Trump wants interest rates down to 1% and would ‘love' Fed chairman Powell to resign
US President Donald Trump has said he wants interest rates to be cut to one per cent and that he would 'love' Federal Reserve chair Jerome Powell to resign. Mr Trump added that he would pick a successor who wants to cut interest rates. 'I'd love him to resign if he wanted to. He's done a lousy job,' Mr Trump said of Mr Powell, speaking at an Oval Office event on Friday. 'If I think somebody's going to keep the rates where they are, or whatever, I'm not going to put them in. 'I'm going to put somebody that wants to cut rates. There are a lot of them out there,' he added. Mr Trump's comments are the latest in a series of attacks on Mr Powell in recent months, increasing his pressure on the Federal Reserve chairman to lower interest rates. Mr Powell so far has resisted and maintains that policy decisions will be data-dependent. The President has argued repeatedly that the central bank's policies are keeping government borrowing costs too high. Mr Powell's term ends in May 2026 and Mr Trump is expected to nominate a successor in the coming months, according to Reuters. The Fed last week kept interest rates unchanged between 4.25 and 4.50 per cent. It has not adjusted rates in its last four meetings, largely due to the uncertainty surrounding Mr Trump's tariffs. Mr Powell last week said tariffs could either have a one-off or persistent effect on inflation. Asked by reporters why not cut interest rates this month, Mr Powell said he expected to see 'meaningful' inflation in the coming months. The Central Bank of the UAE, which follows Fed decisions because of the dollar peg, also held rates steady following the US central bank's most recent decision. The Fed has held rates steady after lowering them by 100 basis points to about 4.33 per cent last year. Its next two-day meeting is on July 29-30.